Irinotecan Noua Zeelandă - engleză - Medsafe (Medicines Safety Authority)

irinotecan

rex medical ltd - irinotecan hydrochloride trihydrate 20 mg/ml;   - solution for injection - 20 mg/ml - active: irinotecan hydrochloride trihydrate 20 mg/ml   excipient: lactic acid sodium hydroxide sorbitol water for injection

Campto 20 mg/ml inf. sol. (conc.) i.v. vial Belgia - engleză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

campto 20 mg/ml inf. sol. (conc.) i.v. vial

pfizer sa-nv - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - topoisomerase 1 (top1) inhibitors

Campto 20 mg/ml inf. sol. (conc.) i.v. vial Belgia - engleză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

campto 20 mg/ml inf. sol. (conc.) i.v. vial

pfizer sa-nv - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - topoisomerase 1 (top1) inhibitors

Campto 20 mg/ml inf. sol. (conc.) i.v. vial Belgia - engleză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

campto 20 mg/ml inf. sol. (conc.) i.v. vial

pfizer sa-nv - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - topoisomerase 1 (top1) inhibitors

Irinotecan Viatris 100 mg/5 ml inf. sol. (conc.) i.v. vial Belgia - engleză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan viatris 100 mg/5 ml inf. sol. (conc.) i.v. vial

viatris gx bv-srl - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

Irinotecan Viatris 40 mg/2 ml inf. sol. (conc.) i.v. vial Belgia - engleză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan viatris 40 mg/2 ml inf. sol. (conc.) i.v. vial

viatris gx bv-srl - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

Irinotecan Viatris 300 mg/15 ml inf. sol. (conc.) i.v. vial Belgia - engleză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan viatris 300 mg/15 ml inf. sol. (conc.) i.v. vial

viatris gx bv-srl - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

Irinotecan Viatris 500 mg/25 ml inf. sol. (conc.) i.v. vial Belgia - engleză - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan viatris 500 mg/25 ml inf. sol. (conc.) i.v. vial

viatris gx bv-srl - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

IRINOTECAN HYDROCHLORIDE 20 Mg/Ml Concentrate for Soln for Inf Irlanda - engleză - HPRA (Health Products Regulatory Authority)

irinotecan hydrochloride 20 mg/ml concentrate for soln for inf

actavis group hf - irinotecan hydrochloride trihydrate - concentrate for soln for inf - 20 mg/ml - other antineoplastic agents

DBL IRINOTECAN INJECTION 500mg/25mL irinotecan hydrochloride trihydrate 500mg/25mL concentrated injection vial Australia - engleză - Department of Health (Therapeutic Goods Administration)

dbl irinotecan injection 500mg/25ml irinotecan hydrochloride trihydrate 500mg/25ml concentrated injection vial

pfizer australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 500 mg - injection, concentrated - excipient ingredients: sorbitol; lactic acid; water for injections - irinotecan injection concentrate is indicated as a component of first-line therapy for patients with metastatic carcinoma of the colon or rectum. irinotecan injection concentrate is also indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.